Study identifier:NIS-CKR-ATA-2007/9
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A prospective, non-interventional, observational, multi-center trial to evaluate compliance and efficacy in mono and combination treatment of Candesartan cilexetil(Atancand)/ Candesartan cilexetil 16mg, hydrochlorothiazide 12.5mg(Atancand plus) in hypertension.
hypertension
N/A
-
-
-
-
Observational
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|